The study will be conducted to evaluate the efficacy and safety of topical administration of PDP-716 compared with brimonidine tartrate ophthalmic solution.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
682
PDP-716
Three Times Brimonidine Tartrate Ophthalmic Solution
Change From Baseline in Mean Intraocular Pressure
Time frame: Week 12 8 AM, 10 AM and 4 PM
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
SPARC Site 4
Chandler, Arizona, United States
SPARC Site 5
Prescott, Arizona, United States
SPARC Site 3
Sun City, Arizona, United States
SPARC Site 38
Burbank, California, United States
SPARC Site 44
Glendale, California, United States
SPARC Site 45
Glendale, California, United States
SPARC Site 43
Mission Hills, California, United States
SPARC Site 1
Newport Beach, California, United States
SPARC Site 14
Santa Barbara, California, United States
SPARC Site 47
Torrance, California, United States
...and 37 more locations